Neudle.com: neuroleptic

Differential
(Click to cross reference)

acetylcholine

advances in neurology

adverse drug reaction

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, treatment of

antibiotics, neurologic complications with

antibodies to voltage-gated calcium channels

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticonvulsants

anticonvulsants, blood level determination of

anticonvulsants, enzyme inducing

anticonvulsants, untoward effects of

arthrogryposis multiplex

aspartate aminotransferase

attention deficit disorder with hyperactivity

atypical

autonomic dysfunction

azidodeoxythymidine

behavior

behavior modification

behavior, combative

behavioral disorder

benzodiazepine

beta adrenergic blocker

brainstem, hemorrhage, primary

calcium antagonist, side effects of

calcium channel dysfunction

CAT scan, emission, abnormal

catatonia

catatonia, lethal

catechol-o-methyltransferase inhibitor

central core disease

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebral cortical atrophy

cerebrovascular accident

cerebrovascular accident, prevention of

chest pain

chewing, impaired

children

chloride channel dysfunction

chromosomal abnormality

chromosome 19

cingulate island sign

citalopram

Clinical Pathologic Conference(C.P.C.)

clubfoot as related to neurologic disease

confusional state, acute

congenital myopathy

congestive heart failure

creatine phosphokinase(CPK)elevated

critical care unit

cultured skin fibroblasts

delirium, work up for

delusion

dementia

dementia, clinical diagnosis

dementia, prevention of

dementia, treatment of

differential diagnosis

dilantin

dilantin, toxicity

dislocated hip, congenital

disseminated intravascular coagulation(DIC)

dopamine depleting agents

drug abuse

drug holiday

drug induced neurologic disorders

drug interactions

drug withdrawal

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dysphagia

dyspnea

dystonia

dystonia, drug induced

dystonia, face

dystonia, treatment of

dystonia, truncal

dystonic reaction, acute

dystrophin

echolalia

efficacy

electrocardiogram, abnormal

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

electron microscopy

emergencies, medical

emergencies, neurologic

epidemiology of neurology

ergotamine

evidence-based research

exercise

extrapyramidal

facial movement disorder

facial weakness

falling

familial

familial hemiplegic migraine

fatigue

fever

fibrinolytic agents, utilization

genetic neurologic disorders

genetic screening

Gilles de la Tourette syndrome

grunting

guanfacine

hallucination

hallucination, visual

headache, intractable

headache, severe

headache, treatment of

heatstroke

hemiballismus

heralding manifestation

hyperammonemic encephalopathy

hypokalemic periodic paralysis

hyponatremia

hyporeflexia

hypotension, systemic

hypotonia

hypotonia, infants

iatrogenic neurologic disorders

impulsivity

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inappropriate behavior

inattention

inclusion bodies

insomnia

intellectual deterioration

interobserver agreement

iron, serum

jealousy

joint hypermobility

kyphoscoliosis, neurologic causes of

lactic acidemia

L-dopa

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

lethargy

leukocytosis

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

lithium

liver function enzymes

lorazepam

lordosis

malignant hyperpyrexia

maprotiline

marihuana

medical-legal aspects of neurology

medication withdrawal

mellaril

memantine

mental retardation

mental status, abnormal

migraine, intractable

migraine, treatment of

mimics

misdiagnosis

mitral valve prolapse

molecular genetics

mortality

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, post hemiplegic

movement disorder, treatment of

multiminicore disease

multiple sclerosis

muscimol

muscle atrophy, static

muscle weakness, proximal

muscular dystrophy

muscular dystrophy, Becker

mutism

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myopathy, drug-induced

neuroleptic induced catatonia

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurological intensive care

neuromuscular blockade

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

nortriptyline

nursing home

obesity

obsessive-compulsive disorder

oculogyric crisis

olanzapine

old age, neurology of

orthostatic hypotension

paramyotonia congenita

paranoia

paraspinal muscle weakness

parietal lobe, atrophy

Parkinson disease

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, fluctuations in

Parkinson disease, misdiagnosis

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, wearing off

Parkinsonism hyperpyrexia syndrome

Parkinsonism syndrome

paroxetine

paroxysmal neurologic deficits

patient information and support

penicillamine

percussion induced muscle contraction

periodic paralysis

phenothiazine

phenothiazine, dyskinesia associated with

physostigmine

pimozide

pimozide, side effects

Pisa syndrome

placebo

poison, neurologic problems with

pontine hemorrhage

posterior cortical atrophy

postoperative neurologic complications

postural abnormality

potassium channel antibodies

potassium channel dysfunction

practice guidelines

premarin

prevention of neurologic disorders

procainamide

progesterone

prognosis

progressive neurologic disorder

propranolol

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

REM sleep behavior disorder

renal failure

renal failure, acute

repetitive questioning

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respiratory dyskinesias

respiratory failure

respiratory myoclonus

restless leg syndrome

risk-benefit assessment

risperidone

rummaging

safety

salivation, excessive

schizophrenia

scoliosis

scoliosis, neurologic association with

sedation

seizure

seizure, drug-induced

seizure, dystonic

selective serotonin reuptake inhibitors

serotonin syndrome

sertraline

serum alanine aminotransferase

sleep pathology and physiology

sneeze

sniffing

snoring

sodium channel dysfunction

sodium nitroprusside

sodium valproate

sodium valproate, intravenous

somnolence

sphingomyelin

spinocerebellar ataxia

spinocerebellar ataxia type 6

stimulation, deep brain

tardive diaphragmatic flutter

tardive dyskinesia

tardive dyskinesia, treatment of

tardive dystonia

tardive pain syndrome

tic, chronic multiple

tic, classification of

tranquilizers, neurologic complications with

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

tremor

tremor, jaw

tremor, treatment of

tricyclic antidepressant

urine osmolality, elevated

wandering

weakness

weakness, progressive

weight gain

Showing articles 100 to 150 of 171 << Previous Next >>

Detecting Susceptibility to Malignant Hyperthermia
BMJ 304:791-792, Ellis,F.R., 1992

Symptomatic and Prophylactic Treatment of Migraine and Tension-Type Headache
Neurol 42:16-21, Schulman,E.A.&Silberstein,S.D., 1992

Missed Neuroleptic Malignant Syndrome
BMJ 304:831-832, Renwick,D.S.,et al, 1992

Tardive Dyskinesia Presenting as Severe Dysphagia
JNNP 55:1203-1204, Gregory,R.P.,et al, 1992

Neuroleptic Sensitivity in Patients with Senile Dementia of Lewy Body Type
BMJ 305:673-678, McKeith,J.,et al, 1992

Clozapine is Beneficial for Psychosis in Parkinson's Disease
NEurol 41:1699-1700, Kahn,N.,et al, 1991

Clozapine, A Novel Antipsychotic Agent
NEJM 324:746-754, Baldessarini,R.J.&Frankenburg,F.R., 1991

Clozapine-Related Seizures
Neurol 41:369-371, Devinsky,O.,et al, 1991

Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991

Controlled-Release Delivery of L-Dopa Associated with Nonfatal Hyperthermia, Rigidity, and Autonomic Dysfunction
Neurol 41:942-943, Cunningham,M.A.,et al, 1991

Serum Iron and Neuroleptic Malignant Syndrome
Lancet 338:149-151, Rosebush,P.I.&Mazurek,M.F., 1991

Prospective Study of Tardvie Dyskinesia Incidence in the Elderly
JAMA 266:2402-2406, Saltz,B.L.,et al, 1991

Adult Sphingomyelinase Deficiency:Report of 2 Patients who Initially Presented with Psychiatric Disorders
Neurol 40:132-136, Dubois,G.,et al, 1990

Clozapine in the Treatment of Parkinsonian Patients with Dopaminomimetic Psychosis
Neurol 40:832-834, Wolters,E.Ch.,et al, 1990

Neuroleptic Malignant Syndrome:A Unique Association with a Tricyclic Antidepressant
Neurol 40:1797-1798, Baca,L.&Martinelli,L., 1990

Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990

Cerebellar Degeneration in Neuroleptic Malignant Synd:Neuropath & Review of Lit Concerning Heat-Related Nervous Syst Injury
JNNP 52:387-391, Lee,S.,et al, 1989

A Pilot Study of Haloperidol Treatment of Psychosis and Behavioral Disturbance in Alzheimer's Disease
Arch Neurol 46:854-857, Devanand,D.P.,et al, 1989

Improved Diagnosis of Becker Muscular Dystrophy by Dystrophin Testing
Neurol 39:1011-1017, Hoffman,E.P.,et al, 1989

Clozapine in the Treatment of Psychosis in Parkinson's Disease
Neurol 39:1219-1221, Friedman,J.H.&Lannon,M.C., 1989

Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989

Neuroleptic Malignant Syndrome:A Case Report with Post-Mortem Brain and Muscle Pathology
JNNP 52:1006-1009, Jones,E.M.&Dawson,A., 1989

Clozapine
Lancet 2:1430-1432, , 1989

Neuroleptic Malignant Syndrome in an Elderly Patient
BMJ 296:18, Finucane,P., 1988

Neuroleptic-Induced Parkinson's Syndrome:Clinical Features and Results of Treatment with Levodopa
JNNP 51:850-854, Hardie,R.J.&Lees,A.J., 1988

Protracted Neuroleptic Malignant Syndrome Complicating Long-Acting Neuroleptic Administration
Am J Med 85:875-878, Legras,A.,et al, 1988

Acute Upper Airway Obstruction Due to Supraglottic Dystonia Induced by a Neuroleptic
BMJ 297:964-965, Newton-John,H., 1988

Neuroleptic Malignant Syndrome:Review and Analysis of 115 Cases
Biol Psychiatry 22:1004-1020, Addonizio,G.,et al, 1987

Peripheral Neuropathy as a Component of the Neuroleptic Malignant Syndrome
Am J Med 82:169-170, Anderson,S.A.&Weinschenk,K., 1987

Treatment of Gilles de la Tourette's Syndrome:Experience in a Predominantly Adult Population
Neurol 37:1828-1833, Mesulam,M.M.&Peterson,R.C., 1987

Central Core Disease, Clinical Features in 13 Patients
Medicine 66:389-396, Shuaid,A.,et al, 1987

Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Int Med 147:1495-1497, Friedman,L.S.,et al, 1987

Effect of Psychotropic Medications on Seizure Control in Patients with Epilepsy
Neurol 37:1525-1527, Ojemann,L.M.,et al, 1987

Successful Treatment of Neuroleptic Malignant Syndrome with Sodium Nitroprusside
Ann Int Med 104:56-57, Blue,M.G.,et al, 1986

Akathisia & Antipsychotic Drugs
Editorial, Lancet 2:1131-11321986., , 1986

The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986

Akathisia-Or not Sitting
BMJ 292:1034-1035, Szabadi,E., 1986

A Neuroleptic Malignantlike Syndrome Due to Levodopa Therapy Withdrawal
JAMA 254:2792-2795, Friedman,J.H.,et al, 1985

Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985

Neuroleptic Malignant Syndrome, Successful Treatment with Pancuronium
JAMA 254:2795-2796, Sangal,R.&Dimitrijevic,R., 1985

Heatstroke in a Chronic Schizophrenic Patient Treated with High-Potency Neuroleptics
General Hospital Psychiatry 7:361-363, Lazarus,A., 1985

Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984

Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984

Neuroleptic Malignant Syndrome Complicated by Disseminated Intravascular Coagulation
Arch Int Med 144:1296-1297, Eles,G.R.,et al, 1984

Drug-Induced Parkinsonism in the Elderly
Lancet 2:1082-1083, Stephen,P.J.,et al, 1984

The Malignant Hyperthermia Syndrome
NEJM 309:416-418, Nelson,T.E.,et al, 1983

Neuroleptic Malignant Syndrome:Response to Dantrolene Sodium
Ann Int Med 98:183-184, May,D.C.,et al, 1983

Beneficial Effects of Dantrolene in the Treatment of Neuroleptic Malignant Syndrome:A Report of Two Cases
Neurol 33:516-518, Goulon,M.,et al, 1983

Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983

Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983

Showing articles 100 to 150 of 171 << Previous Next >>